Financial results - UROCARE ONCOLOGY S.R.L.

Financial Summary - Urocare Oncology S.r.l.
Unique identification code: 39701765
Registration number: J40/11087/2018
Nace: 8622
Sales - Ron
238.934
Net Profit - Ron
57.199
Employee
1
The most important financial indicators for the company Urocare Oncology S.r.l. - Unique Identification Number 39701765: sales in 2023 was 238.934 euro, registering a net profit of 57.199 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Urocare Oncology S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - 476 9.767 56.394 118.692 199.850 238.934
Total Income - EUR - - - - 476 9.767 56.394 118.692 199.850 238.960
Total Expenses - EUR - - - - 529 6.317 22.986 78.769 156.900 179.419
Gross Profit/Loss - EUR - - - - -53 3.450 33.408 39.923 42.949 59.541
Net Profit/Loss - EUR - - - - -68 3.157 31.774 37.010 39.349 57.199
Employees - - - - 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 19.9%, from 199.850 euro in the year 2022, to 238.934 euro in 2023. The Net Profit increased by 17.969 euro, from 39.349 euro in 2022, to 57.199 in the last year.

Check the financial reports for the company - Urocare Oncology S.r.l.

Rating financiar

Financial Rating -
Urocare Oncology S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Urocare Oncology S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Urocare Oncology S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Urocare Oncology S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Urocare Oncology S.r.l. - CUI 39701765

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - 981 935 1.738 1.432 30.298 21.021
Current Assets - - - - 665 3.263 35.244 72.117 39.348 34.089
Inventories - - - - 0 0 1.479 5.441 6.411 8.163
Receivables - - - - 0 0 819 8.482 23.068 16.759
Cash - - - - 665 3.263 32.946 58.194 9.869 9.166
Shareholders Funds - - - - -14 3.143 34.857 71.095 39.400 57.250
Social Capital - - - - 54 53 52 51 51 51
Debts - - - - 1.660 1.054 2.124 2.454 30.247 -2.139
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 34.089 euro in 2023 which includes Inventories of 8.163 euro, Receivables of 16.759 euro and cash availability of 9.166 euro.
The company's Equity was valued at 57.250 euro, while total Liabilities amounted to -2.139 euro. Equity increased by 17.969 euro, from 39.400 euro in 2022, to 57.250 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Urocare Oncology S.r.l.

Comments - Urocare Oncology S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.